abnormal biopsies (16 cases) or proteinuria > 16 g/24 h (2 cases); and C, 11 patients with both decreased function and abnormal histology. Positive latex fixation tests for rheumatoid factor were found in none of group A, four (22%) of group B, and five (45%) of group C patients. Sera heated 560C for 30 min contained precipitins reactive with heat-aggregated IgG in none of seven group A, five of ten (50%) group B, and four of ten (40%) group C patients. The quantity of 'I-labeled patient globulin which bound to immunoadsorbents coated with Cohn fraction II in competition with an equal quantity of 'I-labeled globulin from pooled plasma of normal donors was also measured. Patient globulins bound in significantly greater quantity (.2 SD) than the control in none of the group A, 7 of 18 (39%) group B, and 7 of 11 (64%) group C patients. Renal biopsies from 18 patients were also studied for the ability to fix fluorescein-conjugated heat-aggregated and native human IgG. None of nine tissue specimens from group A or B patients fixed either fluorescein-conjugated protein whereas tissue from eight of nine group C patients showed glomerular localization of one or both reagents. Severity of disease as judged by renal
INTRODUCTION
Experience with patients with chronic glomerulonephritis and with the experimental models which mimic the human disease has emphasized that there are many factors which influence the severity of the disease and the rate of progression to renal insufficiency (1) (2) (3) (4) (5) (6) ). Yet at the onset of disease in many cases it is still difficult to identify those in whom glomerular inflammation and scarring will remit or progress in an aggressive manner (7) (8) .
In rheumatoid arthritis (RA),' on the other hand, a disease in which antigen-antibody complexes also provoke inflammation and contribute to tissue injury, the prognosis to some extent correlates with the level of rheumatoid factors. Indeed, the inflammatory response evoked by antigen-antibody complexes in the synovia may be increased by antiglobulin present in the tissue (9) (10) (11) (12) . Similarly in some patients with systemic lupus erythematosus (SLE) and glomerulonephritis, cryoglobulins with antiglobulin activity may be found in 
METHODS
Patient population 41 consecutive patients whose diagnostic renal biopsies were submitted for histological examination were studied. Clinical records were reviewed to evaluate current and past levels of renal function and to search for clues to the etiology of the renal disease. On the basis of this clinical review and the histology of the renal biopsy without consideration of the results of immunofluorescence studies, patients were classified into three groups (Tables I and II Frozen tissue sections were evaluated by using fluoresceinconjugated reagents specific for human IgA, IgG, and IgM as previously described (18, 19) . The intensity of fluorescence was graded on a 1 to 3+ scale.
There was sufficient renal tissue in 18 cases to evaluate the ability of the glomerular deposits to bind native and aggregated human IgG (20, 21) . Human IgG was extracted from Cohn fraction II (FII) (Pentex Research Products Div., Miles Laboratories Inc., Kankakee, Ill.) by DEAEcellulose chromatography and labeled at a 1: 1 molar fluorescein-to-protein ratio (18) . After rechromatography on DEAE-cellulose (22) , aliquots were aggregated at 630C for 20 min. Tissue sections were incubated with aggregated IgG at a concentration of 1.5-2.0 mg/ml and with some of the same labeled IgG which had not been heated ("native" IgG) at concentrations of 3.0 mg/ml. Care was taken to test tissue sections promptly after removal from the cryostat without prior fixation.
In one case (patient 1) a surgical biopsy was available. Tissue sections from this patient were also tested with aggregated and native fluorescein-labeled human IgG which had been adsorbed with 0.5 mg insolubilized human IgG per mg of fluorescein-conjugated protein. Blocking studies were carried out with unconjugated native and aggregated IgG used at the same protein concentration as the aggregated IgG conjugate and with unconjugated antibodies specific for human IgG, IgA, and IgM (18) . Tissue sections which had been heated to 560C for 30 min in a bath containing 0.15 M NaCl, buffered at pH 7.4 with 0.01 M phosphate (PBS) before incubation with conjugates of aggregated and native human IgG were also studied.
Serologic techniques
Immunoadsorbent assay to measure reactivity of sera to insolubilized FII and other antigens. Patient sera were precipitated three times with 20.4% sodium sulfate. After dialysis, the sulfate-free globulins were labeled with 125I by the iodine monochloride method (23) . '2I-patient globulins were mixed with an equal weight of 'mI-labeled globulin of approximately the same specific activity prepared from pooled plasma from healthy normal donors. The mixture of 'I-patient and 'I-normal globulins was filtered through a adsorbents were washed three times in 10 vol of PBS and 0.22-/tm membrane and incubated at 220C for 2 h and then counted for radioactivity. After correction for the quantities at 4'C overnight with immunoadsorbents coated either with of normal and patient globulins present in the original inhuman FII, fragments of human glomerular basement cubation mixture the quantity of patient globulin less the membranes (GBM), or ovalbumin (OVA) (24) . Measure-quantity of 'I-normal globulin which remained bound was ments were performed in triplicate. After incubation, the used as the measure of antibody activity in the patient sample. Net antibody activity was calculated according to the formula: (micrograms patient globulin bound/milligrams patient globulin added) -(micrograms control globulin bound/milligrams control globulin added) =net activity (micrograms/milligram). Globulins eluted from the washed adsorbents with 0.1 M phthallate-HCI, pH 3, (18, 24) were also measured by radioactive counting. To ensure that the "I-labeled control for nonspecific binding had uniform binding characteristics it was adsorbed with FII and human GBM immunoadsorbents before use.
Preparation of immunoadsorbents. FII and OVA immunoadsorbents were prepared as previously described with bentonite clay as the insoluble matrix (24) . (5 X (Fig. 2) . Binding of the control varied over a relatively narrow range among all samples tested (60.1±+12.9 itg/mg, mean+SD). In 14 cases the bound quantity of patient globulin exceeded the binding of its own control by 2 SD or more (Table II) . Approximately 20% of the globulins which bound to the adsorbent could be eluted at pH 3. The quantity eluted was proportional to that which bound initially, and there was little overlap in the quantities of eluate obtained with the patient and the control samples (Fig. 3) . Measurement of the net Each point represents the mean of at least triplicate measurements for one or more serum samples for each patient. The severity index is a numerical value which takes into account both renal clearance and histological abnormalities in the renal biopsy. The mean value for the normal controls is shown as zero on the ordinate. tients in groups B and C. Overall the severity indices correlated with the level of FII-binding globulin (Table I) (Spearman rank correlation test, r = 0.465, n = 41, P < 0.01; Kruskal-Wallis one-way analysis of variance, H = 15.56 equivalent to chi-square for df = 2 of > 14, P <0.001).
In 28 patients who did not have SLE (Fig. 4) , the net quantity of this serum factor correlated particularly well with the severity index (r = 0.629, P < 0.001, Spearman rank test, n = 28). On the other hand in 13 patients with SLE there was no correlation between the level of FII-binding globulin and the severity indices (r = 0.325, P> 0.10, Spearman rank correlation test, n 13). Only two SLE patients (nos. 1 A and B reacted with these conjugated proteins. On the other hand, tissue from eight or nine group C patients fixed one or both reagents. In four cases, the glomerular deposits selectively fixed heat-aggregated IgG; tissues from the other four reacted with both native and denatured immunoglobulin. In two of the latter cases, it was unlikely that the tissue had any unusual affinity for fluoresceinated proteins. It is conceivable that the native IgG contained antibodies reactive with antigens in the glomeruli of these four group C patients. If so, it is hard to imagine why it reacted selectively with the tissues from the most (29) and this also may be the basis for these reactions. Biopsies from a second series of patients are being studied for the ability to fix fluorescein-labeled proteolytic fragments of IgG to evaluate the specificity of this reaction.
In one case, heating the tissue sections did not abolish fixation of fluorescein-labeled heat-aggregated IgG whereas this property could be blocked with unconjugated anti-IgM, suggesting that IgM antiglobulins rather than Clq were responsible for the tissue localization of aggregated IgG in this patient. Since the tissue sections from other patients were not heated before testing with aggregated IgG (21), we cannot exclude the possibility that Clq rather than antibodies specific for native or heat-aggregated IgG was responsible, in some, for the tissue-fixed antiglobulin activity (30) . Antiglobulins were also detected more frequently by the latex fixation and precipitin tests in sera from patients with groups B and C renal disease. The serum precipitins and the latex reactive factors were' heat stabile and therefore unlikely to represent Clq activity. However, patients whose sera contained antiglobulin activity did not necessarily have antiglobulin deposits in their renal tissues. The poor correlation between the histological and serological observations suggested that the latex and precipitin tests were not detecting all antiglobulins in these patients' sera (31) . Therefore it was desirable to develop a more comprehensive test for antiglobulin activity. Standard radioimmunoassay procedures were precluded by the intrinsic properties of IgG as antigen, viz., its insolubility under the conditions required for the Farr assay and its reactivity with antiimmunoglobulin isotype sera used to separate antigen-antibody complexes from free antigen (32, 33) . While human Fab and Fc antigenic fragments have been used in a modified Farr assay for antiglobulin (34) , this approach precludes the measurement of antibodies reactive with antigens which reflect the quaternary structural characteristics of the molecule (35) . Moreover, antiglobulin factors commonly react with antigenic sites which are exposed only in IgG molecules which have been deformed as a result of antigenantibody reactions or denaturation (29) . With these considerations in mind the immunoadsorbent assay used in these studies was adopted.
Although this test produced a higher frequency of positive reactions than the latex fixation test and correlated well with the severity index (except in patients with SLE) it did not provide a specific measure of antiglobulin antibody and its results did not correlate with the latex fixation or antiglobulin precipitin assays.
The high nonspecific binding of normal globulins by OVA and GBM immunoadsorbents which were used as specificity controls in this assay ensured that these also became de facto immunoadsorbents for antiglobulin. As a result it is probable that this assay appeared to be more nonspecific than it actually was. Unfortunately, an average of only 20% of the globulins which bound to any of the three immunoadsorbents could be eluted with acidic buffers. Therefore, adequate characterization of the FII-binding globulins or those which reacted with OVA and GBM adsorbents was not possible.
Attempts to eluate antiglobulins from kidneys have also met with a low incidence of success (36, 37) , except in some patients with SLE and cryoglobinemia (13) (14) (15) 38 Although these data suggest that antiglobulins are found more frequently in the tissues and sera of patients with relatively severe glomerular injury, they do not necessarily indicate that antiglobulins influence the inflammatory response within the glomeruli. In experimental animals, human antiglobulins are not directly nephrotoxic (16) . Moreover, they are not thought to be directly nephrotoxic in man, either. Patients who have RA and high levels of circulating rheumatoid factors for months or years generally do not develop glomerulonephritis. Indeed, it has been suggested that rheumatoid factors may actually protect kidneys under certain circumstances from deposition of immune complexes (5, 39) . Most likely this would occur in circumstances where the antiglobulins increased the size of immune complexes above that which readily deposit in glomerular capillaries. In vitro evidence can also be cited to suggest that, under certain conditions, antiglobulins can inhibit complement-mediated tissue injury (40, 41) . On the other hand, McCormick, Day, Morris, and Hill have presented data which suggest that antiglobulin-rich serum fractions can augment the tissue injury caused by nephrotoxic antisera (16) . If the correlation between disease severity and presence of antiglobulins in sera or glomeruli in these patients indeed reflects a pathogenic role for antiglobulins in human glomerulonephritis, one can envision at least two mechanisms by which they could augment renal glomerular injury: (a) antiglobulins could combine with antigen-antibody complexes while these were still in the circulation and facilitate their deposition in the kidney and (b) they could bind to immune complexes or GBM-reactive antibodies after these had impinged on the glomerular membranes. In either case, one would expect an apparent increase in the quantity of immunoglobulin deposited in the glomeruli and/or also an increase in the quantity of complement activated at that site. In experimental nephritis, it is recognized that the extent of glomerular injury is closely related to the quantity of immunoglobulin and antigen deposited in the renal glomeruli (42, 43) . In this patient population, however, there was no correlation between histologic evidence of glomerular injury or presence of glomerular antiglobulin deposits and the intensity of the immunofluorescence seen with anti-IgG, anti IgA, or anti-IgM conjugates. In fact, intensely fluorescent deposits were often found with these reagents in tissue from patients (group A) who had little other histologic evidence of glomerulonephritis. Thus, these observations do not support the notion that antiglobulins increase glomerular immunoglobulin deposition, and it is not presently clear whether the antiglobulin response in patients with severe nephritis represents an uninvolved witness or a contributing influence to the intense renal inflammation which has occurred in such patients.
